Relay Therapeutics, Inc.
RLAY· Nasdaq
Relay Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +2.63%
- Market cap
- $4.15B
- 219.14M shares
- Filings
- 547
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $15,355,000 | reported | |
| FY 2024 | 2024-12-31 | $10,007,000 | reported | |
| FY 2023 | 2023-12-31 | $25,546,000 | reported | |
| FY 2022 | 2022-12-31 | $1,381,000 | reported | |
| FY 2021 | 2021-12-31 | $3,029,000 | reported | |
| FY 2020 | 2020-12-31 | $82,654,000 | reported |
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
